Plain-English translation of NCT06798376 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research looks at patients with advanced stomach cancer who received PD-1 inhibitor treatment (an immunotherapy that helps your immune system fight cancer) combined with chemotherapy before surgery. The trial compares two groups: those who received 4 or fewer cycles of treatment versus those who received 5 or more cycles. The goal is to understand whether a longer course of this combination treatment leads to better tumor shrinkage and safer outcomes.
Doctors want to know the best length of pre-surgery treatment for stomach cancer patients. By studying whether more cycles of this medication improve results without causing more complications, researchers hope to personalize treatment plans and help future patients have the best possible outcomes.
You likely qualify if…
You likely don't qualify if…
This is a retrospective study, meaning researchers will review your existing medical records and treatment history — you will not need to attend new visits or undergo new procedures. Doctors will analyze your medical data from when you received your pre-surgery immunotherapy cycles and chemotherapy, and from your subsequent gastric surgery, to compare outcomes between patients who received shorter versus longer treatment courses.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
China